Medico Remedies Limited has informed the stock exchanges about actions taken by regulatory bodies. The company received Show Cause Notices (SoP Notices) from both NSE and BSE on May 20, 2026, for alleged non-compliance with Regulation 6(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The alleged non-compliance pertains to the period from January 1, 2026, to February 17, 2026. The company was required to pay a penalty of ₹56,640 (inclusive of GST) to each exchange. Medico Remedies Limited paid the requisite fines to both NSE and BSE on May 25, 2026. The company stated that there is no material impact on its financials, operations, or other activities due to this matter. As of February 18, 2026, the company is compliant with the said regulation. The delay in disclosure was attributed to an inadvertent omission, and the company has assured that such failures will not occur in the future.
